Xeris Pharmaceuticals | XERS - Loan Capital


Xeris Pharmaceuticals reported $220.33M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Celltrion KRW 63.29B 4.01B Sep/2025
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 20M 0 Mar/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Kangmei Pharma CNY 78.45M 5.8M Sep/2025
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.5M 167K Dec/2025
Nektar Therapeutics USD 63.16M 44.35M Dec/2025
Organigram Holdings CAD 62.52M 13.88M Dec/2025
Ovoca Bio EUR 0 0 Jun/2021
Pacira USD 372.19M 4.53M Dec/2025
Perrigo USD 3.6B 4.5M Dec/2025
Pharma Mar EUR 36.68M 1.07M Dec/2025
Qiagen NV USD 1.65B 15.23M Dec/2025
Sartorius EUR 3.41B 682.5M Sep/2025
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Tilray USD 268.59M 3.82M Sep/2025
Zealand Pharma A/S 383.14M 727K Dec/2025
Zz Pientze Pharmaceu CNY 186.56M 9.75M Sep/2025